Skip to main content
Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: Autoimmune inner ear disease in a melanoma patient treated with pembrolizumab

Fig. 2

Baseline (left column) and post-pembrolizumab (right column) therapy representative PET/CT images. Side-by-side comparative images of PET/CT scan at baseline and after the first four doses of pembrolizumab. Yellow arrows denote sites of active or previously identified melanoma deposits. (1 and 2) Primary sphenoethmoidal mass showing a CR after treatment. (3 and 4) CR in a left hepatic lobe liver metastasis. (5 and 6) CR in two intra-abdominal metastatic implants and in a vertebral metastasis

Back to article page